Fresenius Kabi USA, LLC 5% Dextrose Injection, USP 5 g per 100 mL 100 mL in a 100 mL recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
The hazard
Lack of Assurance of Sterility
Recall details
- Recall number
- D-0436-2026
- Published
- April 15, 2026
- Risk level
- Class II
- Status
- Ongoing
- Issued by
- U.S. Food and Drug Administration
- Brand
- Fresenius Kabi USA, LLC
- Product type
- Prescription & OTC drugs
- Distribution
- Nationwide
- Made in
- United States
- Lot / code info
- Batch# 6402399, 6402400, 6402401, Exp Date: 02/28/2027.
Products covered by this recall
5% Dextrose Injection, USP 5 g per 100 mL (50 mg per mL) 100 mL in a 100 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Use NDC: 65219-464-05, Unit of Sale NDC Number: 65219-464-50.
What to do if you are taking this medicine
Do not stop a prescription on your own. A recalled drug is usually still safer than an untreated condition, and your pharmacist can swap the lot the same day.
- Compare the lot number and expiry date on your bottle or carton with the codes listed above. Only those lots are recalled.
- Keep taking the medicine until you have spoken to your prescriber or pharmacist, unless the notice above says to stop immediately. Abruptly stopping some drugs is more dangerous than the defect itself.
- Call the pharmacy that dispensed it. They can see which lot they gave you and will normally replace it from unaffected stock at no charge.
- Report any side effect you think the product caused to the FDA MedWatch programme at fda.gov/medwatch — that reporting is what triggers most drug recalls in the first place.
Refunds and replacements
With medicines, a replacement supply matters more than cash, and that is what pharmacies are set up to provide.
- Ask the dispensing pharmacy for a like-for-like replacement from an unaffected lot. This is the fastest route and usually costs you nothing.
- If you paid out of pocket, ask for a refund of the co-pay or purchase price; keep the receipt the pharmacy issues for the return.
- For a mail-order or online pharmacy, use the recall line listed on this page rather than the general support queue — recall claims are handled separately.
- If the recall voided a prescription you had already paid for in full, your insurer will normally re-authorise a replacement fill ahead of schedule. Mention the recall number when you call.
Company contact: Fresenius Kabi USA, LLC — 3 Corporate Dr, Lake Zurich, IL, 60047-8930
The official notice
This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.
Open the FDA — Drug enforcement record U.S. Food and Drug Administration recalls
Related recalls
-
Class I · last month
Fresenius Kabi USA, LLC Tyenne Injection, 400 mg/20 mL , 20 mL vial recall: Presence of particulate matter:An internal investigation at the firm found
Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles.
-
Class I · 2 months ago
Fresenius Kabi USA, LLC Morphine Sulfate Injection, USP, 2 mg /mL recall: Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL
Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.
-
Class II · 3 months ago
Fresenius Kabi USA, LLC Naropin , 0.5%, 100 mg per 20 mL , Twenty-five recall: Presence of Particulate Matter: Hair was found in products
Presence of Particulate Matter: Hair was found in products
-
Class II · 3 months ago
Fresenius Kabi USA, LLC Xylocaine , 1%, 200 mg per 20 mL , 25 Multiple-Dose Vials recall: Presence of Particulate Matter: Hair was found in products
Presence of Particulate Matter: Hair was found in products
-
Class II · 3 months ago
Fresenius Kabi USA, LLC Lidocaine HCl Injection, USP, 2%, 100 mg per 5 mL recall: Presence of Particulate Matter: Hair was found in products
Presence of Particulate Matter: Hair was found in products
-
Class II · 3 months ago
Fresenius Kabi USA, LLC Xylocaine , 1%, 500 mg per 50 mL , 25 Multiple-Dose Vials recall: Presence of Particulate Matter: Hair was found in products
Presence of Particulate Matter: Hair was found in products